ArtryaASX:AYA -1.33%30 OCF Yield % is -2.48 as of Jun. 28, 2026. GuruFocus rates ASX:AYA with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 683 Healthcare Providers & Services companies, Artrya ranks worse than 76.28% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Artrya's OCF Yield % or its related term are showing as below:
ASX:AYA'
s OCF Yield % Range Over the Past 10 Years
Min: -2.48 Med: 0 Max: -2.48
Current: -2.48
During the past 5 years, the highest OCF Yield % of Artrya was -2.48%. The lowest was -2.48%. And the median was %.
ASX:AYA's OCF Yield % is ranked worse than 76.28% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 5.51
vs ASX:AYA: -2.48
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Artrya OCF Yield % Related Terms
Artrya OCF Yield % Historical Data
* Premium members only.
The historical data trend for Artrya's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AYA vs VEEV, BTSG, TEM: OCF Yield % Comparison
For the Health Information Services subindustry, Artrya's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artrya OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artrya's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Artrya's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artrya (ASX:AYA) has a OCF Yield % of -2.48 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Artrya and its competitors. According to the industry distribution chart, Artrya ranks #521 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 76.3%.
Is Artrya's OCF Yield % too high?
Artrya's current OCF Yield % is -2.48. Based on the distribution chart, Artrya ranks #521 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Artrya has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Artrya's OCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Artrya ranks #521 out of 683 companies for OCF Yield %. This places Artrya in the lower half of its industry. The industry median OCF Yield % is 5.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.51, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Artrya and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artrya's current OCF Yield % is -2.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artrya stock overvalued right now?
Artrya (ASX:AYA) has a current OCF Yield % of -2.48. The current OCF Yield % is -2.48. Artrya's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Artrya (ASX:AYA), the current OCF Yield % is -2.48 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Artrya Ltd is a medical technology company. The company is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. It is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
30GF Score
Get the complete analysis for ASX:AYA
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AYA has been successfully added to your 
